Some seriously ill patients could get access to certain experimental Schedule I drugs through their doctors. Doctors would need a special federal registration and would have to follow strict supply, storage, and record rules.
Modern Action explains legislation in plain English, helps you choose whether to support, oppose, or ask for changes, and drafts a message tied to the bill, your stance, and the elected officials who can act on it.
Freedom to Heal Act of 2025 is a Senate bill in committee. The latest recorded action: Read twice and referred to the Committee on the Judiciary.
Latest action on S. 3346: Read twice and referred to the Committee on the Judiciary.
Who this affects: This bill mainly affects seriously ill patients, their doctors, and companies developing experimental Schedule I drugs. Patients could have a clearer way to seek certain experimental treatments outside a clinical trial. Doctors would face a new registration process and strict handling rules. Drug makers or sponsors would still decide whether to provide the drug and instructions for its use.
Why this matters: This bill matters because some experimental treatments are hard to use when they are also Schedule I controlled substances. It would give doctors a clearer federal route to treat eligible Right to Try patients with those drugs. It could help some patients who have few other options. But access would still depend on drug makers, state law, federal rules, and safeguards against misuse.
You do not have to start with a blank letter. Modern Action turns the bill, your position, and the relevant congressional context into a message you can edit and send. The goal is to make contacting Congress clear, specific, and useful without forcing you to parse bill text or figure out the right office on your own.
Keep acting on Modern Action
Compare the broader issue and related bills without leaving Modern Action.
